Dental laser manufacturer Biolase Inc. has received U.S. Food and Drug Administration approval of its Epic Pro laser systems, offering higher laser power than most diode lasers in dentistry. The Epic Pro is the first commercially available laser system resulting from Biolase’s strategic development agreement with IPG Medical Corp., a subsidiary of IPG Photonics Corp., reached in 2015. “The collaboration between IPG Medical and Biolase has been exciting,” said Gregory Altshuler, president of IPG Medical. “The Epic Pro with IPG Medical’s super pulse diode laser offers all new computer-controlled thermal super pulsing capability with real-time tip temperature monitoring and automatic power control designed to assist dentists in performing procedures quickly and with great precision. This new feature is a very significant innovation that we believe will provide the technological basis for other clinical modalities.” The Epic Pro laser system received marketing authorization in international markets last year and can now be sold in the U.S. “We are proud to expand the Biolase product portfolio by introducing the Epic Pro as our premium diode laser solution,” said Harold C. Flynn, Jr., president and CEO of Biolase. “There is nothing else like it on the market. The high-end capabilities of this new laser, such as its cutting speed, power and control, allow us to access market segments we have not been able to before, such as the oral and maxillofacial surgeon markets, which previously had not been interested in diode lasers.” Biolase develops, manufactures, markets and sells laser systems in dentistry and medicine and distributes dental imaging equipment including digital x-rays and CAD/CAM scanners.